Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

Update: 2024-08-01

Description

Join us as we explore Theriva Biologics' innovative approach to oncolytic virus therapies, aimed at improving survival rates for difficult-to-treat cancers like brain tumors and pancreatic cancers. Learn about their leading candidate, VCN-01, and the promising results seen in clinical trials for various types of cancer. Discover how Theriva is pushing the boundaries with next-generation viruses like VCN-11 with Albumin Shield technology, paving the way for future advancements in cancer treatment.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Revolutionizing Drug Discovery with Quantum Computing and Sustainability Showcase at WETEX

2024-10-0302:51

Innovations in Water Sustainability: From Ammonia Production to Fog Harvesting

2024-10-0102:58

Innovations in Sustainability, Cardiovascular Health, and the Mysteries of Electricity

2024-09-2603:52

Innovations in Cancer Treatment and Care Coordination for Children with Trisomy 21

2024-09-1304:24

Cardiovascular Health in Pregnancy and Pain Therapeutics Summit Preview

2024-09-0803:09

Exploring Blood Pressure Management, Longevity Science, and UFO Sightings

2024-09-0507:19

Innovations in Health and Space: PAD Prevention and Texas' Space Vision

2024-09-0403:06

Advancements in Water Resource Forecasting and Uranium Market Resurgence

2024-08-2303:03

The Future of Autonomous Aviation with Horizon Aircraft CEO Brandon Robinson

2024-08-1501:58

Breakthrough in Satellite-Characterization Upgrades and High-Speed Rail Resilience Study

2024-08-1503:09

Exploring Growth Opportunities: Panther Minerals Inc.'s Expansion in the Uranium Market

2024-08-1402:12

Exploring Next-Generation Treatment for Major Depressive Disorder with Alzamend Neuro, Inc.

2024-08-1202:11

Exploring Li-FT Power's Lithium Exploration in Canada with CEO Francis MacDonald

2024-08-0901:39

Revolutionizing Bipolar Disorder Treatment with AL001 and Enhancing Corn Lines with Light Technology

2024-08-0603:58

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

2024-08-0102:10

Hope on the Horizon: Promising Treatment for Pancreatic Cancer

2024-07-3102:06

Advancements in Mental Health Treatment and Mineral Exploration Efforts

2024-07-3002:50

Exploring New Horizons: Golden Shield Resources Acquires Tucano Gold & Classiq Launches Qmod

2024-07-2402:51

Mining and Exploration Updates, Clinical Study on Depression, and TechBio Startup Launch

2024-07-1807:46

Mining Stocks Surge, Giant Sequoias Decline, and Copper Exploration Update

2024-07-1604:38

00:00

1.0x

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

#box-pro-ellipsis-173177316041210{-webkit-line-clamp:2;}Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies

NewsRamp

Breaking Barriers: Theriva Biologics' Novel Approach to Oncolytic Virus Therapies